Health in Niger 1,104 indicators covering health for Niger. IndicatorLatest Year10-yr change Rank Hiv expenditure 9.88 million 2023 down 27.2% 64th Number of new leprosy cases with G2D among children 0 2024 — 35th Neonates protected at birth against neonatal tetanus (PAB) 83.0% 2022 down 1.2% 74th Prevalence of overweight, weight for height 1.2% 2022 up 50.0% 89th Most sold brand of cigarettes - price in currency reported 500 2020 up 25.0% 42nd Most sold brand of cigarettes - taxes as a % of price - total tax 0.3% 2020 up 6.7% 150th Most sold brand of cigarettes - taxes as a % of price - ad valorem exc 0.1% 2020 up 15.4% 70th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 34th Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 unchanged 32nd Most sold brand of cigarettes - taxes as a % of price - value added ta 0.2% 2020 unchanged 40th Most sold brand of cigarettes - taxes as a % of price - specific excis 0.0% 2020 — 129th Most sold brand of cigarettes - price in US$ at official exchange rate 0.9 2020 up 13.9% 164th Number healthy diet unaffordable 23.30 million 2024 up 25.9% 21st Import of environmentally sound technologies 128.67 million 2020 down 55.6% 139th Percentage of people living with HIV who know their HIV status 80 2025 up 37.9% 89th Percentage of people living with HIV who know their status receiving a 83 2025 up 16.9% 80th Most sold brand of cigarettes - price in PPP$ 1.95 2020 up 8.3% 170th Export of environmentally sound technologies 4.33 million 2020 down 39.3% 136th Pcv3 number unvaccinated 144,384 2023 down 79.2% 29th Proportion of births delivered in a health facility (Facility births) 44.6% 2021 up 49.7% 123rd Number of non-autochthonous leprosy cases 4 2024 — 23rd Prevalence of wasting, weight for height, female 9.7% 2022 down 20.5% 11th Prevalence of wasting, weight for height, male 12.1% 2022 down 17.1% 6th Number reported cases of cholera 5,591 2021 up 140.6% 4th Population with basic handwashing facilities at home 19.8% 2024 up 62.1% 86th Prevalence of severe wasting, weight for height, female 1.9% 2022 up 5.6% 13th Prevalence of severe wasting, weight for height, male 2.4% 2022 down 29.4% 15th Prevalence of overweight, weight for height, female 0.5% 2022 down 28.6% 84th Prevalence of overweight, weight for height, male 1.8% 2022 up 100.0% 72nd Prevalence of underweight, weight for age, female 32.3% 2022 up 7.0% 2nd Prevalence of underweight, weight for age, male 36.9% 2022 up 9.2% 2nd Prevalence of stunting, height for age, female 45.0% 2022 up 21.3% 3rd Prevalence of stunting, height for age, male 50.4% 2022 up 18.6% 2nd How many health warnings are approved by the law for cigarette packagi 8 2022 up 300.0% 75th Tuberculosis - new and relapse cases 10,325 2011 up 101.9% 58th Number of reported cholera deaths 166 2021 up 176.7% 3rd Diarrhea treatment 40.8% 2015 up 131.8% 50th Pregnant women receiving prenatal care 83.5% 2021 up 0.8% 82nd Percentage of principal display area mandated to be covered by health 70 2022 up 40.0% 20th New cases: pulmonary smear-negative 1,989 2012 up 162.1% 54th Estimated number of pregnant women living with HIV needing antiretrovi 2,000 2025 unchanged 43rd Percentage of principal display area mandated to be covered by health 70 2022 up 40.0% 20th Percentage of principal display area mandated to be covered by health 70 2022 up 40.0% 25th Average death rate due to natural disasters 2.7 2019 up 434.6% 45th Number of full-time equivalent staff in national agency 2 2022 unchanged 78th Total number of notified TB cases 11,102 2014 up 56.1% 53rd The number of people with susceptibility test result for rifampicin am 1,127 2021 — 63rd Estimated number of pregnant women living with HIV 49 2025 unchanged 71st New cases: pulmonary smear unknown/not done 0 2012 — 109th Smear-positive tuberculosis treatment-success rate 80.0% 2011 up 25.0% 97th Share of one year olds who received the rotavirus vaccine 90 2024 up 373.7% 25th How many health warnings are approved by the law for other smoked toba 8 2022 up 300.0% 69th Percentage of principal display area mandated to be covered by health 70 2022 up 40.0% 17th The number of people with susceptibility test result for rifampicin am 11.2 2021 — 138th Contraceptive prevalence, any method 12.2% 2023 down 2.2% 62nd Percentage of principal display area mandated to be covered by health 70 2022 up 40.0% 19th Percentage of principal display area mandated to be covered by health 70 2022 up 40.0% 17th Number of presumed malaria cases 58,581 2024 down 96.2% 21st Contraceptive prevalence, any modern method 11.1% 2023 up 0.9% 62nd Number of indigenous malaria cases 6.90 million 2024 up 188.5% 10th ← Previous Page 16 of 19 Next →